VoxCell BioInnovation key facts
- Developer of 3D (three-dimensional) bioprinted human tissue models designed to enhance drug development and testing accuracy.
- It has raised $12.3M across 2 recorded rounds; the latest was Seed Round ($1.7M) in Feb 2025.
- Notable investors include Creative Destruction Lab, Desjardins Capital, YSpace (Toronto), CABHI, Life Sciences BC — 24 tracked in total.
- VoxCell BioInnovation has filed 2 Form Ds with the SEC since 2024, most recently Mar 2025 ($1.7M sold to 10 investors).
- Status: Privately Held (backing).
Who backs VoxCell BioInnovation
24+- ·The complete investor list: 24 names
- ·Watch VoxCell BioInnovation: the Monday email on marks, rounds and moves
VoxCell BioInnovation funding rounds
2 roundsHow much has VoxCell BioInnovation raised?
VoxCell BioInnovation has raised $12.3 million in total; 2 of its rounds are on record. The largest on record was a $1.7 million seed round in Feb 2025.
VoxCell BioInnovation has filed 2 Form Ds with the SEC since 2024, most recently in Mar 2025 ($1.7 million sold to 10 investors).
VoxCell BioInnovation investors
24 investors are on record for VoxCell BioInnovation, including Creative Destruction Lab, Desjardins Capital, YSpace (Toronto) and CABHI. The seed round in Feb 2025 drew 10 investors.
About VoxCell BioInnovation
Developer of 3D (three-dimensional) bioprinted human tissue models designed to enhance drug development and testing accuracy. The company offers vascularized, physiologically relevant tissue constructs that replicate human biology, enabling pharmaceutical researchers and drug developers to predict clinical outcomes and accelerate therapeutic discovery.
- Sector
- Healthcare
- HQ
- Victoria, Canada
- Founded
- 2020
- Employees
- 27
- Website
- voxcell.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
VoxCell BioInnovation doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.